Molecular Weight:   | 298.16 |
Volume:   | 327.983 |
LogP:   | 5.18 |
LogD:   | 4.217 |
LogS:   | -5.75 |
# Rotatable Bonds:   | 6 |
TPSA:   | 39.44 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 0 |
# Rings:   | 2 |
# Heavy Atoms:   | 3 |
QED Drug-Likeness Score:   | 0.564 |
Synthetic Accessibility Score:   | 2.498 |
Fsp3:   | 0.316 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Rejected |
GSK Rule:   | Rejected |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.732 |
MDCK Permeability:   | 1.9790806618402712e-05 |
Pgp-inhibitor:   | 0.704 |
Pgp-substrate:   | 0.008 |
Human Intestinal Absorption (HIA):   | 0.006 |
20% Bioavailability (F20%):   | 0.312 |
30% Bioavailability (F30%):   | 0.991 |
Blood-Brain-Barrier Penetration (BBB):   | 0.029 |
Plasma Protein Binding (PPB):   | 97.11608123779297% |
Volume Distribution (VD):   | 0.699 |
Pgp-substrate:   | 3.836439609527588% |
CYP1A2-inhibitor:   | 0.959 |
CYP1A2-substrate:   | 0.475 |
CYP2C19-inhibitor:   | 0.858 |
CYP2C19-substrate:   | 0.113 |
CYP2C9-inhibitor:   | 0.719 |
CYP2C9-substrate:   | 0.933 |
CYP2D6-inhibitor:   | 0.679 |
CYP2D6-substrate:   | 0.884 |
CYP3A4-inhibitor:   | 0.475 |
CYP3A4-substrate:   | 0.242 |
Clearance (CL):   | 11.498 |
Half-life (T1/2):   | 0.174 |
hERG Blockers:   | 0.05 |
Human Hepatotoxicity (H-HT):   | 0.832 |
Drug-inuced Liver Injury (DILI):   | 0.747 |
AMES Toxicity:   | 0.017 |
Rat Oral Acute Toxicity:   | 0.009 |
Maximum Recommended Daily Dose:   | 0.243 |
Skin Sensitization:   | 0.9 |
Carcinogencity:   | 0.142 |
Eye Corrosion:   | 0.005 |
Eye Irritation:   | 0.921 |
Respiratory Toxicity:   | 0.057 |
Natural Product ID:   | NPC180006 |
Common Name*:   | Auraptene |
IUPAC Name:   | 7-[(2E)-3,7-dimethylocta-2,6-dienoxy]chromen-2-one |
Synonyms:   | 7-Geranyloxycoumarin; Auraptene |
Standard InCHIKey:   | RSDDHGSKLOSQFK-RVDMUPIBSA-N |
Standard InCHI:   | InChI=1S/C19H22O3/c1-14(2)5-4-6-15(3)11-12-21-17-9-7-16-8-10-19(20)22-18(16)13-17/h5,7-11,13H,4,6,12H2,1-3H3/b15-11+ |
SMILES:   | CC(=CCC/C(=C/COc1ccc2ccc(=O)oc2c1)/C)C |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL307341 |
PubChem CID:   |
1550607 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO27288 | Citrus maxima | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | DOI[10.1016/S0031-9422(99)00119-3] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[10606547] |
NPO7317 | Citrus aurantium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[10606602] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[10654410] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[10843587] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | Roots | n.a. | n.a. |
PMID[15568770] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[16392664] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[16933887] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | roots | Hualien Hsien, Taiwan | 2003-JUL |
PMID[16933887] |
NPO31471 | Poncirus trifoliata | Species | Rutaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[17666859] |
NPO5270 | Citrus natsudaidai | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[17689080] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. |
PMID[17951038] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[18175961] |
NPO5045 | Aegle marmelos | Species | Rutaceae | Eukaryota | leaves | n.a. | n.a. |
PMID[18760601] |
NPO5045 | Aegle marmelos | Species | Rutaceae | Eukaryota | n.a. | bark | n.a. |
PMID[21875114] |
NPO5045 | Aegle marmelos | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[23434131] |
NPO21771 | Citrus trifoliata | Species | Rutaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[23872723] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[24295087] |
NPO8528 | Citrus junos | Species | Rutaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[25522543] |
NPO5045 | Aegle marmelos | Species | Rutaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[26247834] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[27575476] |
NPO30202 | Rutaceae | Genus | Rutaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[27771936] |
NPO27785 | Atalantia buxifolia | Species | Rutaceae | Eukaryota | Twigs | n.a. | n.a. |
PMID[29975532] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | Roots | n.a. | n.a. |
PMID[30298740] |
NPO5045 | Aegle marmelos | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[30579794] |
NPO21771 | Citrus trifoliata | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[32996318] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | Roots | n.a. | n.a. |
PMID[9868163] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | root | n.a. | Database[Article] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | Bark | n.a. | n.a. | Database[FooDB] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | Fruit | n.a. | n.a. | Database[FooDB] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | Fruit Juice | n.a. | n.a. | Database[FooDB] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | Pericarp | n.a. | n.a. | Database[FooDB] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | Root Bark | n.a. | n.a. | Database[FooDB] |
NPO27288 | Citrus maxima | Species | Rutaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO8528 | Citrus junos | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO16308 | Citrus wilsonii | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO8698 | Zanthoxylum schinifolium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO5045 | Aegle marmelos | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7317 | Citrus aurantium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO31471 | Poncirus trifoliata | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO27785 | Atalantia buxifolia | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO27288 | Citrus maxima | Species | Rutaceae | Eukaryota | n.a. | n.a. | Database[Phenol-Explorer] | |
NPO8528 | Citrus junos | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO27288 | Citrus maxima | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO21771 | Citrus trifoliata | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO8698 | Zanthoxylum schinifolium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO5045 | Aegle marmelos | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7317 | Citrus aurantium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO27785 | Atalantia buxifolia | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO16308 | Citrus wilsonii | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO8698 | Zanthoxylum schinifolium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO5045 | Aegle marmelos | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO7317 | Citrus aurantium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO31471 | Poncirus trifoliata | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO16308 | Citrus wilsonii | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO27785 | Atalantia buxifolia | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO5270 | Citrus natsudaidai | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[Title] |
NPO5270 | Citrus natsudaidai | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO8698 | Zanthoxylum schinifolium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO16308 | Citrus wilsonii | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO21771 | Citrus trifoliata | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO27288 | Citrus maxima | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO7317 | Citrus aurantium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO27288 | Citrus maxima | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8698 | Zanthoxylum schinifolium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19787 | Citrus sinensis | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19231 | Sophora flavescens | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO5270 | Citrus natsudaidai | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO9366 | Rosa transmorrisonensis | Species | Rosaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24248.1 | Lactarius deliciosus var. deterrimus | Varieties | Russulaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO27785 | Atalantia buxifolia | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7317 | Citrus aurantium | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO21771 | Citrus trifoliata | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO16308 | Citrus wilsonii | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO1117 | Hypholoma capnoides | Species | Strophariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8528 | Citrus junos | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO2629 | Cystoseira caespitosa | Species | Sargassaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | > | 500000.0 | nM | PMID[489147] |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | IC50 | = | 47000.0 | nM | PMID[489147] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 31622.8 | nM | PMID[489150] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 28183.8 | nM | PMID[489150] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 35481.3 | nM | PMID[489151] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 70794.6 | nM | PMID[489152] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 10000.0 | nM | PMID[489150] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 12589.3 | nM | PMID[489152] |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 7079.5 | nM | PMID[489151] |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[489150] |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 35481.3 | nM | PMID[489150] |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 31622.8 | nM | PMID[489152] |
NPT524 | Individual Protein | Serine-protein kinase ATM | Homo sapiens | Potency | = | 22387.2 | nM | PMID[489151] |
NPT501 | Individual Protein | Alpha-galactosidase A | Homo sapiens | Potency | = | 14125.4 | nM | PMID[489152] |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[489150] |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[489152] |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[489151] |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 22387.2 | nM | PMID[489152] |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[489151] |
NPT15 | Cell Line | Jurkat | Homo sapiens | IC50 | = | 55.36 | ug.mL-1 | PMID[489153] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 82000.0 | nM | PMID[489154] |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 65000.0 | nM | PMID[489154] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | IC50 | = | 87000.0 | nM | PMID[489154] |
NPT114 | Cell Line | LoVo | Homo sapiens | IC50 | = | 66000.0 | nM | PMID[489154] |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[489151] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[489151] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[489151] |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | n.a. | 37933.0 | nM | PMID[489151] |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[489150] |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 0.895 | n.a. | PMID[489157] |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 1.005 | n.a. | PMID[489157] |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 1.017 | n.a. | PMID[489157] |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 1.26 | n.a. | PMID[489157] |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 2.084 | n.a. | PMID[489157] |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 5.897 | n.a. | PMID[489157] |
NPT540 | Individual Protein | Bile acid receptor FXR | Homo sapiens | FC | = | 11.67 | n.a. | PMID[489157] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 11582.1 | nM | PMID[489151] |
NPT156 | Individual Protein | Sphingomyelin phosphodiesterase | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[489151] |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | n.a. | 19952.6 | nM | PMID[489151] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | -3.79 | % | PMID[489159] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[489151] |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[489151] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 18356.4 | nM | PMID[489151] |
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | n.a. | 79432.8 | nM | PMID[489151] |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | CC50 | = | 7000.0 | nM | PMID[489164] |
NPT4046 | Individual Protein | Melatonin receptor 1A | Homo sapiens | Ki | = | 1900.0 | nM | PMID[489166] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 80000.0 | nM | PMID[489166] |
NPT457 | Cell Line | BT-549 | Homo sapiens | IC50 | = | 24000.0 | nM | PMID[489166] |
NPT83 | Cell Line | MCF7 | Homo sapiens | Efficacy | = | 90.0 | % | PMID[489166] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Efficacy | = | 67.0 | % | PMID[489166] |
NPT457 | Cell Line | BT-549 | Homo sapiens | Efficacy | = | 86.0 | % | PMID[489166] |
NPT83 | Cell Line | MCF7 | Homo sapiens | Inhibition | = | 3.0 | % | PMID[489166] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | -36.0 | % | PMID[489166] |
NPT457 | Cell Line | BT-549 | Homo sapiens | Inhibition | = | 7.0 | % | PMID[489166] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 3.4 | mg m-1 | PMID[489145] |
NPT32 | Organism | Mus musculus | Mus musculus | Reduction | = | 51.0 | % | PMID[489145] |
NPT451 | Organism | Helicobacter pylori | Helicobacter pylori | MIC | = | 50.0 | ug.mL-1 | PMID[489146] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 28183.8 | nM | PMID[489152] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 28183.8 | nM | PMID[489150] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[489151] |
NPT864 | Individual Protein | Lethal(3)malignant brain tumor-like protein 1 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[489151] |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[489152] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 82000.0 | nM | PMID[489154] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 58000.0 | nM | PMID[489154] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | GI | = | 90.0 | % | PMID[489154] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 58.0 | % | PMID[489154] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 7375.3 | nM | PMID[489151] |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | n.a. | 89125.1 | nM | PMID[489151] |
NPT740 | Individual Protein | Beta-secretase 1 | Homo sapiens | IC50 | = | 345100.0 | nM | PMID[489156] |
NPT2 | Others | Unspecified | IC50 | = | 6300.0 | nM | PMID[489158] | |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | IC50 | = | 23900.0 | nM | PMID[489158] |
NPT2 | Others | Unspecified | Potency | n.a. | 44668.4 | nM | PMID[489151] | |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 1.5 | % | PMID[489159] |
NPT87 | Organism | Aspergillus fumigatus | Aspergillus fumigatus | log(1/MIC) | = | 2.16 | n.a. | PMID[489160] |
NPT185 | Organism | Aspergillus flavus | Aspergillus flavus | MIC | >= | 2048.0 | ug.mL-1 | PMID[489160] |
NPT87 | Organism | Aspergillus fumigatus | Aspergillus fumigatus | MIC | >= | 2048.0 | ug.mL-1 | PMID[489160] |
NPT2 | Others | Unspecified | Inhibition | = | 30.0 | % | PMID[489161] | |
NPT22409 | PROTEIN COMPLEX | Mitochondrial complex I (NADH dehydrogenase) | Homo sapiens | IC50 | = | 18800.0 | nM | PMID[489161] |
NPT22409 | PROTEIN COMPLEX | Mitochondrial complex I (NADH dehydrogenase) | Homo sapiens | IC50 | = | 10200.0 | nM | PMID[489161] |
NPT893 | Individual Protein | Monoamine oxidase B | Mus musculus | IC50 | = | 0.0006 | nM | PMID[489162] |
NPT892 | Individual Protein | Monoamine oxidase A | Mus musculus | IC50 | = | 0.0346 | nM | PMID[489162] |
NPT2 | Others | Unspecified | IC50 | = | 0.0017 | nM | PMID[489162] | |
NPT2 | Others | Unspecified | Potency | n.a. | 15848.9 | nM | PMID[489151] | |
NPT2 | Others | Unspecified | Potency | n.a. | 316.2 | nM | PMID[489150] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | LC50 | = | 21000.0 | nM | PMID[489163] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | LC50 | > | 100000.0 | nM | PMID[489163] |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 1.0 | n.a. | PMID[489164] | |
NPT2 | Others | Unspecified | IC50 | = | 7000.0 | nM | PMID[489164] | |
NPT2 | Others | Unspecified | IC50 | = | 57000000.0 | nM | PMID[489166] | |
NPT2 | Others | Unspecified | Efficacy | = | 57.0 | % | PMID[489166] | |
NPT2 | Others | Unspecified | Inhibition | = | 5.0 | % | PMID[489166] | |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 39.1 | % | PMID[489167] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 68.4 | % | PMID[489167] |
NPT32 | Organism | Mus musculus | Mus musculus | FC | = | 2.2 | n.a. | PMID[489167] |
NPT22410 | CELL-LINE | Melan-a | Mus musculus | FC | = | 1.3 | n.a. | PMID[489168] |
NPT22410 | CELL-LINE | Melan-a | Mus musculus | FC | = | 2.0 | n.a. | PMID[489168] |
NPT893 | Individual Protein | Monoamine oxidase B | Mus musculus | IC50 | = | 600.0 | nM | PMID[489171] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[489172] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[489172] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC180006 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC235190 |
0.9825 | High Similarity | NPC163200 |
0.9823 | High Similarity | NPC281356 |
0.9735 | High Similarity | NPC265547 |
0.9649 | High Similarity | NPC298796 |
0.9573 | High Similarity | NPC109675 |
0.9573 | High Similarity | NPC273772 |
0.9561 | High Similarity | NPC96705 |
0.9561 | High Similarity | NPC152306 |
0.9558 | High Similarity | NPC128633 |
0.9492 | High Similarity | NPC201667 |
0.9492 | High Similarity | NPC73413 |
0.9492 | High Similarity | NPC27671 |
0.9487 | High Similarity | NPC248429 |
0.9487 | High Similarity | NPC96286 |
0.9417 | High Similarity | NPC121740 |
0.9417 | High Similarity | NPC258567 |
0.9417 | High Similarity | NPC224774 |
0.9407 | High Similarity | NPC472518 |
0.9339 | High Similarity | NPC469453 |
0.9339 | High Similarity | NPC472519 |
0.925 | High Similarity | NPC471827 |
0.925 | High Similarity | NPC471828 |
0.9244 | High Similarity | NPC315807 |
0.9237 | High Similarity | NPC144418 |
0.9187 | High Similarity | NPC19242 |
0.9187 | High Similarity | NPC113098 |
0.9174 | High Similarity | NPC188327 |
0.9174 | High Similarity | NPC234109 |
0.9174 | High Similarity | NPC101894 |
0.9167 | High Similarity | NPC291899 |
0.916 | High Similarity | NPC13007 |
0.916 | High Similarity | NPC257188 |
0.9113 | High Similarity | NPC272650 |
0.9113 | High Similarity | NPC29734 |
0.9113 | High Similarity | NPC267336 |
0.9106 | High Similarity | NPC168710 |
0.9098 | High Similarity | NPC243688 |
0.9083 | High Similarity | NPC290605 |
0.9083 | High Similarity | NPC50720 |
0.9083 | High Similarity | NPC154176 |
0.9083 | High Similarity | NPC173350 |
0.9076 | High Similarity | NPC52247 |
0.9068 | High Similarity | NPC247553 |
0.904 | High Similarity | NPC14248 |
0.9032 | High Similarity | NPC80170 |
0.9024 | High Similarity | NPC157212 |
0.9024 | High Similarity | NPC185066 |
0.9024 | High Similarity | NPC199204 |
0.9016 | High Similarity | NPC471826 |
0.9008 | High Similarity | NPC111347 |
0.9 | High Similarity | NPC150214 |
0.8992 | High Similarity | NPC319378 |
0.8992 | High Similarity | NPC302107 |
0.8968 | High Similarity | NPC2363 |
0.8968 | High Similarity | NPC296624 |
0.8968 | High Similarity | NPC318400 |
0.8968 | High Similarity | NPC7526 |
0.8968 | High Similarity | NPC167111 |
0.8968 | High Similarity | NPC471910 |
0.8968 | High Similarity | NPC31849 |
0.8968 | High Similarity | NPC133956 |
0.8968 | High Similarity | NPC469449 |
0.8968 | High Similarity | NPC207002 |
0.8968 | High Similarity | NPC36437 |
0.8968 | High Similarity | NPC241341 |
0.8968 | High Similarity | NPC222036 |
0.8968 | High Similarity | NPC233018 |
0.8952 | High Similarity | NPC474289 |
0.8938 | High Similarity | NPC149545 |
0.8934 | High Similarity | NPC93219 |
0.8934 | High Similarity | NPC244495 |
0.8917 | High Similarity | NPC187868 |
0.8898 | High Similarity | NPC198381 |
0.8898 | High Similarity | NPC267412 |
0.8898 | High Similarity | NPC84894 |
0.8898 | High Similarity | NPC195343 |
0.8898 | High Similarity | NPC55149 |
0.8898 | High Similarity | NPC319859 |
0.8898 | High Similarity | NPC47163 |
0.8898 | High Similarity | NPC74655 |
0.8898 | High Similarity | NPC100986 |
0.8898 | High Similarity | NPC18804 |
0.8898 | High Similarity | NPC307412 |
0.8898 | High Similarity | NPC166672 |
0.8898 | High Similarity | NPC260265 |
0.8898 | High Similarity | NPC287182 |
0.8898 | High Similarity | NPC164269 |
0.8898 | High Similarity | NPC127888 |
0.8889 | High Similarity | NPC137669 |
0.886 | High Similarity | NPC106141 |
0.8828 | High Similarity | NPC471909 |
0.8828 | High Similarity | NPC86892 |
0.8828 | High Similarity | NPC471625 |
0.8828 | High Similarity | NPC469675 |
0.8828 | High Similarity | NPC472424 |
0.8828 | High Similarity | NPC281241 |
0.878 | High Similarity | NPC232692 |
0.878 | High Similarity | NPC202594 |
0.877 | High Similarity | NPC143725 |
0.8761 | High Similarity | NPC157473 |
0.8761 | High Similarity | NPC151530 |
0.876 | High Similarity | NPC283331 |
0.876 | High Similarity | NPC149320 |
0.876 | High Similarity | NPC128529 |
0.876 | High Similarity | NPC160727 |
0.876 | High Similarity | NPC471630 |
0.876 | High Similarity | NPC55615 |
0.876 | High Similarity | NPC26954 |
0.876 | High Similarity | NPC177281 |
0.876 | High Similarity | NPC38099 |
0.876 | High Similarity | NPC283019 |
0.876 | High Similarity | NPC476455 |
0.875 | High Similarity | NPC326600 |
0.875 | High Similarity | NPC213173 |
0.875 | High Similarity | NPC180716 |
0.875 | High Similarity | NPC50896 |
0.875 | High Similarity | NPC224475 |
0.875 | High Similarity | NPC204353 |
0.875 | High Similarity | NPC62366 |
0.874 | High Similarity | NPC194277 |
0.874 | High Similarity | NPC175159 |
0.874 | High Similarity | NPC19157 |
0.874 | High Similarity | NPC469956 |
0.874 | High Similarity | NPC319969 |
0.873 | High Similarity | NPC244799 |
0.873 | High Similarity | NPC240722 |
0.873 | High Similarity | NPC32463 |
0.872 | High Similarity | NPC139595 |
0.872 | High Similarity | NPC60704 |
0.872 | High Similarity | NPC293642 |
0.871 | High Similarity | NPC127604 |
0.8692 | High Similarity | NPC471069 |
0.8692 | High Similarity | NPC155963 |
0.8692 | High Similarity | NPC131198 |
0.8692 | High Similarity | NPC306365 |
0.8692 | High Similarity | NPC471068 |
0.8692 | High Similarity | NPC14697 |
0.8684 | High Similarity | NPC291837 |
0.8682 | High Similarity | NPC472525 |
0.8682 | High Similarity | NPC229128 |
0.8673 | High Similarity | NPC176971 |
0.8672 | High Similarity | NPC163557 |
0.8672 | High Similarity | NPC54503 |
0.8672 | High Similarity | NPC55147 |
0.8672 | High Similarity | NPC469955 |
0.8672 | High Similarity | NPC469952 |
0.8661 | High Similarity | NPC472517 |
0.8651 | High Similarity | NPC123127 |
0.8651 | High Similarity | NPC27239 |
0.864 | High Similarity | NPC194841 |
0.864 | High Similarity | NPC289316 |
0.8629 | High Similarity | NPC168259 |
0.8626 | High Similarity | NPC164148 |
0.8626 | High Similarity | NPC307883 |
0.8626 | High Similarity | NPC471070 |
0.8626 | High Similarity | NPC279573 |
0.8626 | High Similarity | NPC211110 |
0.8626 | High Similarity | NPC151946 |
0.8626 | High Similarity | NPC471071 |
0.8626 | High Similarity | NPC43500 |
0.8626 | High Similarity | NPC471072 |
0.8605 | High Similarity | NPC309953 |
0.8605 | High Similarity | NPC98179 |
0.8605 | High Similarity | NPC253574 |
0.8595 | High Similarity | NPC193193 |
0.8595 | High Similarity | NPC31314 |
0.8595 | High Similarity | NPC473290 |
0.8595 | High Similarity | NPC471504 |
0.8584 | High Similarity | NPC128730 |
0.8584 | High Similarity | NPC139891 |
0.8571 | High Similarity | NPC33717 |
0.8571 | High Similarity | NPC474651 |
0.8571 | High Similarity | NPC474623 |
0.8561 | High Similarity | NPC312881 |
0.856 | High Similarity | NPC163248 |
0.855 | High Similarity | NPC232246 |
0.855 | High Similarity | NPC153818 |
0.8538 | High Similarity | NPC66705 |
0.8538 | High Similarity | NPC33986 |
0.8538 | High Similarity | NPC61499 |
0.8537 | High Similarity | NPC288238 |
0.8534 | High Similarity | NPC231251 |
0.8534 | High Similarity | NPC25067 |
0.8534 | High Similarity | NPC88868 |
0.8527 | High Similarity | NPC472524 |
0.8516 | High Similarity | NPC250727 |
0.8512 | High Similarity | NPC59561 |
0.8512 | High Similarity | NPC172253 |
0.8509 | High Similarity | NPC326447 |
0.85 | High Similarity | NPC471498 |
0.85 | High Similarity | NPC471503 |
0.8496 | Intermediate Similarity | NPC300611 |
0.8496 | Intermediate Similarity | NPC152771 |
0.8496 | Intermediate Similarity | NPC155552 |
0.8496 | Intermediate Similarity | NPC287286 |
0.8496 | Intermediate Similarity | NPC472523 |
0.8496 | Intermediate Similarity | NPC195357 |
0.8496 | Intermediate Similarity | NPC138149 |
0.8485 | Intermediate Similarity | NPC253616 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC180006 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9076 | High Similarity | NPD422 | Phase 1 |
0.8584 | High Similarity | NPD9697 | Approved |
0.8571 | High Similarity | NPD1008 | Clinical (unspecified phase) |
0.8509 | High Similarity | NPD3134 | Approved |
0.8438 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8385 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.8385 | Intermediate Similarity | NPD5124 | Phase 1 |
0.8295 | Intermediate Similarity | NPD1296 | Phase 2 |
0.8279 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8276 | Intermediate Similarity | NPD1358 | Approved |
0.8222 | Intermediate Similarity | NPD1652 | Phase 2 |
0.8134 | Intermediate Similarity | NPD2796 | Approved |
0.8083 | Intermediate Similarity | NPD5535 | Approved |
0.806 | Intermediate Similarity | NPD3748 | Approved |
0.8 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7986 | Intermediate Similarity | NPD6799 | Approved |
0.7969 | Intermediate Similarity | NPD3225 | Approved |
0.792 | Intermediate Similarity | NPD5691 | Approved |
0.7907 | Intermediate Similarity | NPD2797 | Approved |
0.7874 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7869 | Intermediate Similarity | NPD1241 | Discontinued |
0.7863 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7826 | Intermediate Similarity | NPD1243 | Approved |
0.7795 | Intermediate Similarity | NPD3496 | Discontinued |
0.7786 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.777 | Intermediate Similarity | NPD3750 | Approved |
0.7769 | Intermediate Similarity | NPD3266 | Approved |
0.7769 | Intermediate Similarity | NPD3267 | Approved |
0.7762 | Intermediate Similarity | NPD1653 | Approved |
0.7744 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7737 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7717 | Intermediate Similarity | NPD1778 | Approved |
0.771 | Intermediate Similarity | NPD1019 | Discontinued |
0.7692 | Intermediate Similarity | NPD920 | Approved |
0.7676 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7674 | Intermediate Similarity | NPD9717 | Approved |
0.7655 | Intermediate Similarity | NPD6599 | Discontinued |
0.7612 | Intermediate Similarity | NPD3268 | Approved |
0.7603 | Intermediate Similarity | NPD7411 | Suspended |
0.7603 | Intermediate Similarity | NPD2684 | Approved |
0.7586 | Intermediate Similarity | NPD8158 | Clinical (unspecified phase) |
0.7578 | Intermediate Similarity | NPD4626 | Approved |
0.7574 | Intermediate Similarity | NPD4340 | Discontinued |
0.7574 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7571 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7569 | Intermediate Similarity | NPD5403 | Approved |
0.7552 | Intermediate Similarity | NPD5401 | Approved |
0.7551 | Intermediate Similarity | NPD6801 | Discontinued |
0.7521 | Intermediate Similarity | NPD290 | Approved |
0.7518 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7518 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1240 | Approved |
0.75 | Intermediate Similarity | NPD7819 | Suspended |
0.75 | Intermediate Similarity | NPD1549 | Phase 2 |
0.75 | Intermediate Similarity | NPD1203 | Approved |
0.75 | Intermediate Similarity | NPD5585 | Approved |
0.75 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD4307 | Phase 2 |
0.75 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7481 | Intermediate Similarity | NPD4749 | Approved |
0.7462 | Intermediate Similarity | NPD1091 | Approved |
0.745 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7431 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7429 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7429 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7422 | Intermediate Similarity | NPD9545 | Approved |
0.7422 | Intermediate Similarity | NPD1894 | Discontinued |
0.741 | Intermediate Similarity | NPD7033 | Discontinued |
0.741 | Intermediate Similarity | NPD1510 | Phase 2 |
0.74 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7391 | Intermediate Similarity | NPD1607 | Approved |
0.7388 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7379 | Intermediate Similarity | NPD7314 | Clinical (unspecified phase) |
0.736 | Intermediate Similarity | NPD7843 | Approved |
0.7353 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7353 | Intermediate Similarity | NPD6798 | Discontinued |
0.7351 | Intermediate Similarity | NPD7075 | Discontinued |
0.7319 | Intermediate Similarity | NPD1933 | Approved |
0.731 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD17 | Approved |
0.7303 | Intermediate Similarity | NPD919 | Approved |
0.7286 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7279 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7273 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7273 | Intermediate Similarity | NPD2981 | Phase 2 |
0.726 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.725 | Intermediate Similarity | NPD846 | Approved |
0.725 | Intermediate Similarity | NPD940 | Approved |
0.7248 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7246 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7246 | Intermediate Similarity | NPD1613 | Approved |
0.7246 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7241 | Intermediate Similarity | NPD7837 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD821 | Approved |
0.7219 | Intermediate Similarity | NPD5402 | Approved |
0.7218 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7218 | Intermediate Similarity | NPD4359 | Approved |
0.7218 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7214 | Intermediate Similarity | NPD2200 | Suspended |
0.7209 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7206 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7197 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7197 | Intermediate Similarity | NPD1611 | Approved |
0.7194 | Intermediate Similarity | NPD6355 | Discontinued |
0.7188 | Intermediate Similarity | NPD7157 | Approved |
0.7188 | Intermediate Similarity | NPD2557 | Approved |
0.7185 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.7174 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7172 | Intermediate Similarity | NPD6666 | Approved |
0.7172 | Intermediate Similarity | NPD6667 | Approved |
0.7171 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7164 | Intermediate Similarity | NPD8651 | Approved |
0.7163 | Intermediate Similarity | NPD2799 | Discontinued |
0.7154 | Intermediate Similarity | NPD968 | Approved |
0.7153 | Intermediate Similarity | NPD7466 | Approved |
0.7153 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7153 | Intermediate Similarity | NPD5163 | Phase 2 |
0.7143 | Intermediate Similarity | NPD1608 | Approved |
0.7132 | Intermediate Similarity | NPD2237 | Approved |
0.7132 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7132 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7132 | Intermediate Similarity | NPD9493 | Approved |
0.7132 | Intermediate Similarity | NPD3596 | Phase 2 |
0.7124 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7123 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7123 | Intermediate Similarity | NPD7213 | Phase 3 |
0.7122 | Intermediate Similarity | NPD4140 | Approved |
0.7121 | Intermediate Similarity | NPD3847 | Discontinued |
0.712 | Intermediate Similarity | NPD5451 | Approved |
0.7113 | Intermediate Similarity | NPD2935 | Discontinued |
0.7105 | Intermediate Similarity | NPD4288 | Approved |
0.7101 | Intermediate Similarity | NPD411 | Approved |
0.7101 | Intermediate Similarity | NPD3374 | Clinical (unspecified phase) |
0.7101 | Intermediate Similarity | NPD1048 | Approved |
0.7095 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7075 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7071 | Intermediate Similarity | NPD447 | Suspended |
0.7071 | Intermediate Similarity | NPD230 | Phase 1 |
0.707 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7067 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7059 | Intermediate Similarity | NPD3882 | Suspended |
0.7054 | Intermediate Similarity | NPD6671 | Approved |
0.705 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7044 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7039 | Intermediate Similarity | NPD2801 | Approved |
0.7039 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD5746 | Approved |
0.7027 | Intermediate Similarity | NPD2186 | Approved |
0.7023 | Intermediate Similarity | NPD6580 | Approved |
0.7023 | Intermediate Similarity | NPD6581 | Approved |
0.7018 | Intermediate Similarity | NPD1282 | Approved |
0.7015 | Intermediate Similarity | NPD3972 | Approved |
0.7014 | Intermediate Similarity | NPD2424 | Discontinued |
0.7013 | Intermediate Similarity | NPD3749 | Approved |
0.7013 | Intermediate Similarity | NPD6971 | Discontinued |
0.7007 | Intermediate Similarity | NPD1511 | Approved |
0.7 | Intermediate Similarity | NPD3140 | Approved |
0.7 | Intermediate Similarity | NPD3142 | Approved |
0.6993 | Remote Similarity | NPD8443 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD6100 | Approved |
0.6993 | Remote Similarity | NPD4476 | Approved |
0.6993 | Remote Similarity | NPD4477 | Approved |
0.6993 | Remote Similarity | NPD6099 | Approved |
0.6978 | Remote Similarity | NPD2313 | Discontinued |
0.6975 | Remote Similarity | NPD7549 | Discontinued |
0.6974 | Remote Similarity | NPD1934 | Approved |
0.6972 | Remote Similarity | NPD7097 | Phase 1 |
0.697 | Remote Similarity | NPD3443 | Approved |
0.697 | Remote Similarity | NPD3049 | Approved |
0.697 | Remote Similarity | NPD6830 | Clinical (unspecified phase) |
0.697 | Remote Similarity | NPD3445 | Approved |
0.697 | Remote Similarity | NPD3444 | Approved |
0.6966 | Remote Similarity | NPD2654 | Approved |
0.6962 | Remote Similarity | NPD7784 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD2534 | Approved |
0.6959 | Remote Similarity | NPD2533 | Approved |
0.6959 | Remote Similarity | NPD2532 | Approved |
0.6957 | Remote Similarity | NPD2614 | Approved |
0.695 | Remote Similarity | NPD4618 | Approved |
0.695 | Remote Similarity | NPD4622 | Approved |
0.6944 | Remote Similarity | NPD6004 | Phase 3 |
0.6944 | Remote Similarity | NPD6005 | Phase 3 |
0.6944 | Remote Similarity | NPD5762 | Approved |
0.6944 | Remote Similarity | NPD5763 | Approved |
0.6944 | Remote Similarity | NPD6003 | Clinical (unspecified phase) |
0.6944 | Remote Similarity | NPD6006 | Clinical (unspecified phase) |
0.6944 | Remote Similarity | NPD6002 | Phase 3 |
0.694 | Remote Similarity | NPD3705 | Approved |
0.694 | Remote Similarity | NPD1535 | Discovery |
0.6939 | Remote Similarity | NPD6652 | Clinical (unspecified phase) |
0.6934 | Remote Similarity | NPD3690 | Phase 2 |
0.6934 | Remote Similarity | NPD2798 | Approved |
0.6934 | Remote Similarity | NPD3691 | Phase 2 |
0.6929 | Remote Similarity | NPD5745 | Approved |
0.6929 | Remote Similarity | NPD8032 | Phase 2 |
0.6923 | Remote Similarity | NPD5494 | Approved |
0.6917 | Remote Similarity | NPD2556 | Approved |
0.6917 | Remote Similarity | NPD6516 | Phase 2 |
0.6917 | Remote Similarity | NPD2554 | Approved |
0.6917 | Remote Similarity | NPD5846 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.